Outlicensing Opportunities for New Partners. Veriton Pharma is seeking to enhance its corporate offering by way of gaining marketing authorisations for selected products.
Veriton Pharma are now looking to out-licence these products outside of their core UK market to interested partners.
Veriton Pharma is currently seeking potential partners with an interest in the CNS sector to market and distribute an epilepsy medication within the EEA and potentially RoW, outside the UK/Australia/MEA.
If you would be interested in taking one of our products and putting through the licensing program within your country please send us a message using the contact us form to discuss outlicensing opportunities further.
Business & Employment Opportunities
We are better together! If you would like to become part of the Veriton Pharma team, we would love to hear from you. Likewise, if you are a pharmaceutical company interested in distributing our products in your country, please contact us.
News
- SERB Announces the Acquisition of Veriton Pharma
- SAPHNA Annual Conference 2019: HEALTH FOR ALL CHILDREN
SAPHNA Annual Conference 2019: 18th June in Manchester We are delighted to be attending the upcoming SAPHNA Annual Conference; HEALTH FOR ALL CHILDREN – School and Public Health Nurses Turning the Tide…. Read More
- Young Epilepsy online guide for school
Veriton Pharma is pleased to announce the online publication of the charity Young Epilepsy’s online guide for schools. This comprehensive resource aimed at improving the management and support of children with epilepsy… Read More
- Young Epilepsy and Veriton Pharma Ltd announce key partnership agreement in support of the charity’s ‘Rules 4 Schools’ campaign
Young Epilepsy and Veriton Pharma Ltd (Veriton) have announced a key agreement, where the organisations will work in partnership to deliver the ‘Rules 4 Schools” element of the charity’s newly… Read More